Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Sep, 2017 | Pages:
105 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Asthma Medication market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Asthma Medication in these regions, from 2012 to 2022 (forecast).
United States Asthma Medication market competition by top manufacturers/players, with Asthma Medication sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals?Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Asthma Medication for each application, including
Children
Adolescent
Adult
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Asthma Medication Market Report 2017
1 Asthma Medication Overview
1.1 Product Overview and Scope of Asthma Medication
1.2 Classification of Asthma Medication by Product Category
1.2.1 United States Asthma Medication Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Asthma Medication Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Quick-Relief Medications
1.2.4 Long-Term Control Medications
1.2.5 Asthma Medications During Pregnancy
1.3 United States Asthma Medication Market by Application/End Users
1.3.1 United States Asthma Medication Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 United States Asthma Medication Market by Region
1.4.1 United States Asthma Medication Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Asthma Medication Status and Prospect (2012-2022)
1.4.3 Southwest Asthma Medication Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Asthma Medication Status and Prospect (2012-2022)
1.4.5 New England Asthma Medication Status and Prospect (2012-2022)
1.4.6 The South Asthma Medication Status and Prospect (2012-2022)
1.4.7 The Midwest Asthma Medication Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Asthma Medication (2012-2022)
1.5.1 United States Asthma Medication Sales and Growth Rate (2012-2022)
1.5.2 United States Asthma Medication Revenue and Growth Rate (2012-2022)
2 United States Asthma Medication Market Competition by Players/Suppliers
2.1 United States Asthma Medication Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Asthma Medication Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Asthma Medication Average Price by Players/Suppliers (2012-2017)
2.4 United States Asthma Medication Market Competitive Situation and Trends
2.4.1 United States Asthma Medication Market Concentration Rate
2.4.2 United States Asthma Medication Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Asthma Medication Manufacturing Base Distribution, Sales Area, Product Type
3 United States Asthma Medication Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Asthma Medication Sales and Market Share by Region (2012-2017)
3.2 United States Asthma Medication Revenue and Market Share by Region (2012-2017)
3.3 United States Asthma Medication Price by Region (2012-2017)
4 United States Asthma Medication Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Asthma Medication Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Asthma Medication Revenue and Market Share by Type (2012-2017)
4.3 United States Asthma Medication Price by Type (2012-2017)
4.4 United States Asthma Medication Sales Growth Rate by Type (2012-2017)
5 United States Asthma Medication Sales (Volume) by Application (2012-2017)
5.1 United States Asthma Medication Sales and Market Share by Application (2012-2017)
5.2 United States Asthma Medication Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Asthma Medication Players/Suppliers Profiles and Sales Data
6.1 Dulera
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Asthma Medication Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Dulera Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 QVAR
6.2.2 Asthma Medication Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 QVAR Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Glaxosmithkline plc
6.3.2 Asthma Medication Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 MAP Pharmaceuticals?Inc
6.4.2 Asthma Medication Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 MAP Pharmaceuticals?Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck & Co. Inc
6.5.2 Asthma Medication Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 AstraZeneca plc
6.6.2 Asthma Medication Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AstraZeneca plc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Roche Holdings Ltd
6.7.2 Asthma Medication Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Roche Holdings Ltd Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Genentech Inc
6.8.2 Asthma Medication Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Genentech Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sepracor, Inc
6.9.2 Asthma Medication Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sepracor, Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Schering-Plough Corp
6.10.2 Asthma Medication Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Sanofi-Aventis
6.12 Theravance Inc
7 Asthma Medication Manufacturing Cost Analysis
7.1 Asthma Medication Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Asthma Medication
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Asthma Medication Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Asthma Medication Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Asthma Medication Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Asthma Medication Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Asthma Medication Sales Volume Forecast by Type (2017-2022)
11.3 United States Asthma Medication Sales Volume Forecast by Application (2017-2022)
11.4 United States Asthma Medication Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Asthma Medication
Figure United States Asthma Medication Market Size (K Units) by Type (2012-2022)
Figure United States Asthma Medication Sales Volume Market Share by Type (Product Category) in 2016
Figure Quick-Relief Medications Product Picture
Figure Long-Term Control Medications Product Picture
Figure Asthma Medications During Pregnancy Product Picture
Figure United States Asthma Medication Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Asthma Medication by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adolescent Examples
Table Key Downstream Customer in Adolescent
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure United States Asthma Medication Market Size (Million USD) by Region (2012-2022)
Figure The West Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Asthma Medication Sales (K Units) and Growth Rate (2012-2022)
Figure United States Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Asthma Medication Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Asthma Medication Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Asthma Medication Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Asthma Medication Sales Share by Players/Suppliers
Figure 2017 United States Asthma Medication Sales Share by Players/Suppliers
Figure United States Asthma Medication Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Asthma Medication Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Asthma Medication Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Asthma Medication Revenue Share by Players/Suppliers
Figure 2017 United States Asthma Medication Revenue Share by Players/Suppliers
Table United States Market Asthma Medication Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Asthma Medication Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Asthma Medication Market Share of Top 3 Players/Suppliers
Figure United States Asthma Medication Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Asthma Medication Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Asthma Medication Product Category
Table United States Asthma Medication Sales (K Units) by Region (2012-2017)
Table United States Asthma Medication Sales Share by Region (2012-2017)
Figure United States Asthma Medication Sales Share by Region (2012-2017)
Figure United States Asthma Medication Sales Market Share by Region in 2016
Table United States Asthma Medication Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Asthma Medication Revenue Share by Region (2012-2017)
Figure United States Asthma Medication Revenue Market Share by Region (2012-2017)
Figure United States Asthma Medication Revenue Market Share by Region in 2016
Table United States Asthma Medication Price (USD/Unit) by Region (2012-2017)
Table United States Asthma Medication Sales (K Units) by Type (2012-2017)
Table United States Asthma Medication Sales Share by Type (2012-2017)
Figure United States Asthma Medication Sales Share by Type (2012-2017)
Figure United States Asthma Medication Sales Market Share by Type in 2016
Table United States Asthma Medication Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Asthma Medication Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Asthma Medication by Type (2012-2017)
Figure Revenue Market Share of Asthma Medication by Type in 2016
Table United States Asthma Medication Price (USD/Unit) by Types (2012-2017)
Figure United States Asthma Medication Sales Growth Rate by Type (2012-2017)
Table United States Asthma Medication Sales (K Units) by Application (2012-2017)
Table United States Asthma Medication Sales Market Share by Application (2012-2017)
Figure United States Asthma Medication Sales Market Share by Application (2012-2017)
Figure United States Asthma Medication Sales Market Share by Application in 2016
Table United States Asthma Medication Sales Growth Rate by Application (2012-2017)
Figure United States Asthma Medication Sales Growth Rate by Application (2012-2017)
Table Dulera Basic Information List
Table Dulera Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dulera Asthma Medication Sales Growth Rate (2012-2017)
Figure Dulera Asthma Medication Sales Market Share in United States (2012-2017)
Figure Dulera Asthma Medication Revenue Market Share in United States (2012-2017)
Table QVAR Basic Information List
Table QVAR Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QVAR Asthma Medication Sales Growth Rate (2012-2017)
Figure QVAR Asthma Medication Sales Market Share in United States (2012-2017)
Figure QVAR Asthma Medication Revenue Market Share in United States (2012-2017)
Table Glaxosmithkline plc Basic Information List
Table Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Glaxosmithkline plc Asthma Medication Sales Growth Rate (2012-2017)
Figure Glaxosmithkline plc Asthma Medication Sales Market Share in United States (2012-2017)
Figure Glaxosmithkline plc Asthma Medication Revenue Market Share in United States (2012-2017)
Table MAP Pharmaceuticals?Inc Basic Information List
Table MAP Pharmaceuticals?Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MAP Pharmaceuticals?Inc Asthma Medication Sales Growth Rate (2012-2017)
Figure MAP Pharmaceuticals?Inc Asthma Medication Sales Market Share in United States (2012-2017)
Figure MAP Pharmaceuticals?Inc Asthma Medication Revenue Market Share in United States (2012-2017)
Table Merck & Co. Inc Basic Information List
Table Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Inc Asthma Medication Sales Growth Rate (2012-2017)
Figure Merck & Co. Inc Asthma Medication Sales Market Share in United States (2012-2017)
Figure Merck & Co. Inc Asthma Medication Revenue Market Share in United States (2012-2017)
Table AstraZeneca plc Basic Information List
Table AstraZeneca plc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca plc Asthma Medication Sales Growth Rate (2012-2017)
Figure AstraZeneca plc Asthma Medication Sales Market Share in United States (2012-2017)
Figure AstraZeneca plc Asthma Medication Revenue Market Share in United States (2012-2017)
Table Roche Holdings Ltd Basic Information List
Table Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Holdings Ltd Asthma Medication Sales Growth Rate (2012-2017)
Figure Roche Holdings Ltd Asthma Medication Sales Market Share in United States (2012-2017)
Figure Roche Holdings Ltd Asthma Medication Revenue Market Share in United States (2012-2017)
Table Genentech Inc Basic Information List
Table Genentech Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech Inc Asthma Medication Sales Growth Rate (2012-2017)
Figure Genentech Inc Asthma Medication Sales Market Share in United States (2012-2017)
Figure Genentech Inc Asthma Medication Revenue Market Share in United States (2012-2017)
Table Sepracor, Inc Basic Information List
Table Sepracor, Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sepracor, Inc Asthma Medication Sales Growth Rate (2012-2017)
Figure Sepracor, Inc Asthma Medication Sales Market Share in United States (2012-2017)
Figure Sepracor, Inc Asthma Medication Revenue Market Share in United States (2012-2017)
Table Schering-Plough Corp Basic Information List
Table Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Schering-Plough Corp Asthma Medication Sales Growth Rate (2012-2017)
Figure Schering-Plough Corp Asthma Medication Sales Market Share in United States (2012-2017)
Figure Schering-Plough Corp Asthma Medication Revenue Market Share in United States (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Theravance Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Asthma Medication
Figure Manufacturing Process Analysis of Asthma Medication
Figure Asthma Medication Industrial Chain Analysis
Table Raw Materials Sources of Asthma Medication Major Players/Suppliers in 2016
Table Major Buyers of Asthma Medication
Table Distributors/Traders List
Figure United States Asthma Medication Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Asthma Medication Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Asthma Medication Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Asthma Medication Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Asthma Medication Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Asthma Medication Sales Volume (K Units) Forecast by Type in 2022
Table United States Asthma Medication Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Asthma Medication Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Asthma Medication Sales Volume (K Units) Forecast by Application in 2022
Table United States Asthma Medication Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Asthma Medication Sales Volume Share Forecast by Region (2017-2022)
Figure United States Asthma Medication Sales Volume Share Forecast by Region (2017-2022)
Figure United States Asthma Medication Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
